RheumaFactor.com
RHEUMD
  • Home
  • News
    & Perspectives
  • Diseases
    & Rheumatic Conditions
  • Clinical Cases
    Reports & Discussions
  • Criteria
    Diagnostic & Classification
  • Blog
    By Georgiev MD

RheuMD

  • RA
  • Spondyloarthritis
  • Osteoarthritis
  • Gout
  • CRA
  • Lupus
  • Other CTDs
  • Vasculitides
  • Osteoporosis
  • Biologics
  • News
  • Biologics
  • Biologics News
Secukinumab Shows Promise as a Treatment Option for Giant Cell Arteritis
Relationship Between Rheumatoid Arthritis Treatments and Cardiovascular Health
Difficult-to-Treat Rheumatoid Arthritis: What Does It Mean?
The Risk for Second Cancer in RA Patients Treated with Biologics
Romosozumab Reduces the Risk of Fracture but May Increase CV risk
ACR/AAHKS: DMARDs Can Be Used in Perioperative Management of Hip and Knee Replacement Surgery
Long-term Treatment of Osteoporosis with Denosumab: Is It a Good Idea?
EMA Releases New Guide on Biosimilar Medicine
Less Myocardial Infarction in RA Patients Treated with TNF inhibitors
Sifalimumab May Be Useful in Refractory to Therapy Systemic Lupus Erythematosus
Canakinumab Is Now Indicated for Adult-Onset Still's Disease
Off-Label Prescription Drugs Use in Pediatric Rheumatology

Popular News

Short Disclaimer

The information provided on RheumaFactor.com is for educational purposes only. RheumaFactor.com does not provide medical advice, diagnosis or treatment. Use of this Web site is subject to the medical disclaimer and terms of use. For more information click here.

About Us

RheumaFactor.com is a source of helpful news and information for medical doctors in the field of rheumatology.

Find Us

  • Contact Us
  • Disclaimer and Terms of Use
  • Cookie Policy
  • Home
  • News
    & Perspectives
  • Diseases
    & Rheumatic Conditions
  • Clinical Cases
    Reports & Discussions
  • Criteria
    Diagnostic & Classification
  • Blog
    By Georgiev MD